Day: May 24, 2021
FDA Approves Rybrevant for Certain Patients with Non-Small Cell Lung Cancer
Lung cancer is a complex disease, accounting for almost 25% of all cancer deaths. The Food and Drug Administration (FDA) has approved Rybrevant for treatment [...]